Cost analysis of remote-only monitoring
| Element of cost | Device; mean cost, $ (95% CI) | |
|---|---|---|
| Implantable cardioverter defibrillator | Pacemaker | |
| Health care | ||
| Actual total costs | 1469 (1379–1559) | 112 (81–143) |
| Counterfactual total costs* | 2130 (2044–2215) | 199 (167–230) |
| Total savings | 660 (642–679) | 86 (86–87) |
| Travel | ||
| Actual costs | 33 (13–53) | 1 (1–2) |
| Counterfactual costs* | 391 (339–444) | 9 (8–10) |
| Cost savings | 358 (299–418) | 8 (7–8) |
Note: CI = confidence interval.
↵* Based on the assumption that the patient had to travel to a specialized site for monitoring at least twice a year, in the absence of remote monitoring, and keeping all other costs the same.